1. Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways
   Nang Lae Lae Phoo et al, 2022, International Journal of Molecular Sciences CrossRef
2. Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death
   Nang Lae Lae Phoo et al, 2021, International Journal of Molecular Sciences CrossRef
3. The Interaction of lncRNA XLOC-2222497, AKR1C1, and Progesterone in Porcine Endometrium and Pregnancy
   Tao Su et al, 2020, International Journal of Molecular Sciences CrossRef
4. Zingiberensis Newsaponin Inhibits the Malignant Progression of Hepatocellular Carcinoma via Suppressing Autophagy Moderated by the AKR1C1-Mediated JAK2/STAT3 Pathway
   Keqing He et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
5. Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis
   Dipankar Bhattacharya et al, 2021, Scientific Reports CrossRef
6. AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression
   Xing Wei et al, 2021, Biochemical Genetics CrossRef
7. Dioscorea Zingiberensis New Saponin Inhibits the Growth of Hepatocellular Carcinoma by Suppressing the Expression of Long Non-coding RNA TCONS-00026762
   Xing Liu et al, 2021, Frontiers in Pharmacology CrossRef
8. ARID3A promotes the chemosensitivity of colon cancer by inhibiting AKR1C3
   Yafei Li et al, 2022, Cell Biology International CrossRef
9. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies
   Mengnan Li et al, 2024, Frontiers in Pharmacology CrossRef
10. Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
    Xiaoning Gan et al, 2020, Frontiers in Genetics CrossRef
11. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis
    Lisha Mou et al, 2023, Frontiers in Immunology CrossRef
12. Bruton’s Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
    Lucie Čermáková et al, 2022, Pharmaceutics CrossRef